U.S. Republicans wrestle with effort to gut Obamacare
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
CIGNA (CI) PT Raised to $164 at Oppenheimer Following 4Q Report
February 3, 2017 9:51 AM ESTOppenheimer raised its price target on CIGNA (NYSE: CI) to $164.00 (from $158.00) while maintaining a Outperform rating following the company's 4Q report. : Following the quarter, Cigna provided conservative FY2017 EPS guidance of $9.00-9.50, but this excludes any contribution from capital deployment.
Analyst Michael Wiederhorn... More
